LIPOPROTEIN(A) AND CARDIOVASCULAR OUTCOMES IN WOMEN AND MEN AFTER AN ACUTE CORONARY SYNDROME: A POST HOC ODYSSEY OUTCOMES TRIAL ANALYSIS

被引：0
|
作者：
Bittner, Vera
Schwartz, Gregory G.
Bhatt, Deepak L.
Diaz, Rafael
Garon, Genevieve
Goodman, Shaun G.
Harrington, Robert A.
Jukema, Johan Wouter
Pordy, Robert
Szarek, Michael
White, Harvey D.
Zeiher, Andreas M.
Steg, Philippe Gabriel
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Paris Cite, Paris, France
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
910-04
引用
收藏
页码：1625 / 1625
页数：1
相关论文
共 50 条
  • [41] Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial
    Diaz, Rafael
    Li, Qian H.
    Bhatt, Deepak L.
    Bittner, Vera A.
    Baccara-Dinet, Marie T.
    Goodman, Shaun G.
    Jukema, J. Wouter
    Kimura, Takeshi
    Parkhomenko, Alexander
    Pordy, Robert
    Reiner, Zeljko
    Roe, Matthew T.
    Szarek, Michael
    Tse, Hung-Fat
    White, Harvey D.
    Zahger, Doron
    Zeiher, Andreas M.
    Schwartz, Gregory G.
    Steg, Ph Gabriel
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (01) : 33 - 43
  • [42] Effect of obstructive sleep apnoea on cardiovascular outcomes in patients with acute coronary syndrome: a secondary analysis of the RICCADSA trial
    Peker, Yuksel
    Thunstrom, Erik
    Glantz, Helena
    Eulenburg, Christine
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [43] Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial"
    Packard, Chris J.
    CIRCULATION, 2020, 142 (20) : E333 - E334
  • [44] Cardiovascular Outcomes After Acute Coronary Syndrome in Persons Living with HIV: A Scoping Review
    David Iskhakov
    Julie N. Deleger
    Jorge Plutzky
    Virginia A. Triant
    Emily P. Hyle
    Current Cardiology Reports, 2025, 27 (1)
  • [45] Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): Implications for the OCEAN(a)-Outcomes trial population
    Shiyovich, A.
    Berman, A.
    Besser, S.
    Biery, D.
    Huck, D.
    Weber, B.
    Cannon, C.
    Januzzi, J.
    Booth, J.
    Nasir, K.
    Di Carli, M.
    Lopez, A.
    Kent, S.
    Bhatt, D.
    Blankstein, R.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [46] Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial
    Lopes, Renato D.
    Guimaraes, Patr Icia O.
    Schwartz, Gregory G.
    Bhatt, Deepak L.
    Bittner, Vera A.
    Budaj, Andrzej
    Dalby, Anthony J.
    Diaz, Rafael
    Goodman, Shaun G.
    Harrington, Robert A.
    Jukema, J. Wouter
    Kiss, Robert Gabor
    Loy, Megan
    Pordy, Robert
    Poulouin, Yann
    Szarek, Michael
    White, Harvey D.
    Steg, Philippe Gabriel
    AMERICAN JOURNAL OF MEDICINE, 2022, 135 (07): : 915 - 918
  • [47] Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
    Bittner, Vera A.
    Szarek, Michael
    Aylward, Philip E.
    Bhatt, Deepak L.
    Diaz, Rafael
    Edelberg, Jay M.
    Fras, Zlatko
    Goodman, Shaun G.
    Halvorsen, Sigrun
    Hanotin, Corinne
    Harrington, Robert A.
    Jukema, J. Wouter
    Loizeau, Virginie
    Moriarty, Patrick M.
    Moryusef, Angele
    Pordy, Robert
    Roe, Matthew T.
    Sinnaeve, Peter
    Tsimikas, Sotirios
    Vogel, Robert
    White, Harvey D.
    Zahger, Doron
    Zeiher, Andreas M.
    Steg, Gabriel
    Schwartz, Gregory G.
    Aylward, Philip E.
    Drexel, Heinz
    Sinnaeve, Peter
    Dilic, Mirza
    Lopes, Renato D.
    Gotcheva, Nina N.
    Prieto, Juan-Carlos
    Yong, Huo
    Lopez-Jaramillo, Patricio
    Pecin, Ivan
    Reiner, Zeljko
    Ostadal, Petr
    Poulsen, Steen Hvitfeldt
    Viigimaa, Margus
    Nieminen, Markku S.
    Danchin, Nicolas
    Chumburidze, Vakhtang
    Marx, Nikolaus
    Liberopoulos, Evangelos
    Montenegro Valdovinos, Pablo Carlos
    Tse, Hung-Fat
    Kiss, Robert Gabor
    Xavier, Denis
    Zahger, Doron
    Valgimigli, Marco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (02) : 133 - 144
  • [48] β-blocker dosage and outcomes after acute coronary syndrome
    Allen, Jason E.
    Knight, Stacey
    McCubrey, Raymond O.
    Bair, Tami
    Muhlestein, Joseph Brent
    Goldberger, Jeffrey J.
    Anderson, Jeffrey L.
    AMERICAN HEART JOURNAL, 2017, 184 : 26 - 36
  • [49] Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke
    Yan-Rong Li
    Sung-Sheng Tsai
    Dong-Yi Chen
    Szu-Tah Chen
    Jui-Hung Sun
    Hung-Yu Chang
    Miaw-Jene Liou
    Tien-Hsing Chen
    Cardiovascular Diabetology, 17
  • [50] Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke
    Li, Yan-Rong
    Tsai, Sung-Sheng
    Chen, Dong-Yi
    Chen, Szu-Tah
    Sun, Jui-Hung
    Chang, Hung-Yu
    Liou, Miaw-Jene
    Chen, Tien-Hsing
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
12345